<DOC>
	<DOCNO>NCT02595658</DOCNO>
	<brief_summary>People Type 1 diabetes ( T1DM ) usually provide guidance best control glycaemia around meal time adjust rapid-acting insulin dose accord carbohydrate content meal ( e.g . 1 IU per 10/15 g carbohydrate ; Schmidt et al. , 2014 ) . However , potential issue around method role dietary fat calculation insulin requirement ( Wolpert et al. , 2013 ) . The fat component meal potential influence insulin dose requirement normalise postprandial glycaemia ( Wolpert et al. , 2013 ) . Although normalise postprandial glycaemia vital , postprandial lipaemia also important consideration long-term health , present scant data area T1DM . In addition , change macronutrient composition food alter insulin dos may carry important implication vascular function prospective appetite regulation . This research examine glycaemic lipaemic response consume mixed meal similar carbohydrate content , differ fat content . Moreover , research ass whether acute postprandial reduction insulin sensitivity offset increase dose rapid-acting insulin meal . Venous blood sample collect 6 hour meal , determination glycaemic lipaemic response , well metabolite hormonal parameter . In addition study assess impact mixed meal adjust insulin dose vascular function subjective rating appetite . The finding study benefit patient type 1 diabetes provision refine self-management strategy insulin dosage around meal-times .</brief_summary>
	<brief_title>Insulin Dose Adjustments Meals Differing Fat Content T1DM</brief_title>
	<detailed_description>Study design Methodology General Design : 18 male female type 1 diabetes ( T1DM ) individual age 18 50 year old invite attend four laboratory session , separate 7 day . Participants recruit clinic advertising local medium . Participants complete four main trial randomise counter balance fashion . Main trial involve manipulation meal composition ( fat content ) rapid-acting insulin dose . During visit blood sample measure 6 hour postprandial period determine glycaemic , lipaemic , hormone , metabolite parameter . Sample size calculation : Sample size requirement estimate use Eq . 1 Hopkins ( 2000 ) : n = 8s2/d2 [ Eq . 1 ] Where n sample size , typical error measurement meaningful effect size . The magnitude derive 0.8 subject variation , calculate use exist data . The postprandial incremental area curve ( AUC ) triglyceride concentration follow mixed-macronutrient meal people T1DM typically 0.74 mmol.l-1.hour-1 , between-subject standard deviation 0.99 mmol.l-1.hour-1 ( Levetan et al . 2003 ) . Therefore calculate 0.79 mmol.l-1.hour-1 . The CV measure derive repeat trial 23 % ( Weiss et al . 2008 ) , give typical error region 0.18 mmol.l-1.hour-1 . These data indicate sample size 18 participant provide great 80 % chance detect statistically significant effect P value &lt; 0.05 . Inclusion/exclusion criterion Participants : For inclusion study , volunteer either male female age 18-50 year old , free diabetes complication apart background diabetic retinopathy , take prescribed medication insulin , treat stable insulin regimen compose combination slow/long act insulin glargine/determir fast acting insulin analogue ( lispro aspart , glulisine ) , HbA1c &lt; 9.5 % ( 80 mmol/mol ) . Participants currently use carbohydrate counting method administer meal time rapid-acting insulin . Prior main trial : Participants instruct follow recommend diet plan 48 hour prior test . Participants require read sign inform consent form medical questionnaire review visit laboratory . 24 hour prior trial , participant fit real-time continuous glucose monitoring system ( CGM ) . The CGM consist sensor insert subcutaneous tissue secure place waterproof adhesive dressing . Sensor reading obtain stored memory monitor attach indwell sensor . Glucose reading provide screen monitor real-time . Alarms set monitor notify participant glucose level low ( &lt; 3.9 mmol/L ) high ( &gt; 14 mmol/L ) pre-trial period . For calibration purpose , participant require input blood capillary blood glucose value minimum 4 time per day ( meal time bed ) use blood glucose finger-prick meter . The CGM remove day trial time convenient participant , late-evening nocturnal glycaemia capture . The CGM monitor also act safety measure alert participant glycaemic excursion follow intervention . Participants instructed use real-time CGM glucose value determine correction blood glucose ( additional carbohydrate / insulin administration ) . Main trial : All trial conduct randomised counter-balanced fashion . For visit , participant require arrive NIHR Clinical Research Facility laboratory morning ( ~07:00 - 09:00 AM ) . On first visit , anthropometric variable collect ( mass , stature , BMI ) prior experimentation . On visit , participant assume seat rested position whilst 18 gauge cannula insert antecubital vein non-dominant arm collection venous blood . This keep patent periodic infusion saline . After cannulation complete , 12 ml rest blood sample collect . Participants perform one four trial : Trial 1 ) Carbohydrate meal : Participants consume standardise carbohydrate meal ( 80 g carbohydrate , 25 g protein , 0 g fat : meal composition , white rice , chicken , curry sauce ; 420 kcal ) self-administer ( subcutaneous tissue abdomen , per regular routine ) rapid-acting insulin dose calculate per carbohydrate-counting ratio ( e.g . 1 IU insulin per 10 g carbohydrate ) . Trial 2 ) Participants replicate Trial 1 , occasion meal consume additional 50 g fat ( via addition Ghee ) . This fat add sauce within meal ( 80 g carbohydrate , 25 g protein , 50 g fat ; 735 Kcal ) . Participants administer rapid-acting insulin per carbohydrate counting method ( i.e . IU insulin per Trial 1 ) . Trial 3 ) Participants replicate Trial 2 , administer rapid-acting insulin dose increase 15 % . Trial 4 ) Participants replicate Trial 2 , administer rapid-acting insulin dose increase 30 % . Once participant consume meal , remain rest 6 hour , 12ml blood sample per hour capture time-course change glycaemia , lipaemia , hormone , metabolite concentration . During first 2 hour , additional 1ml sample take 15 45 minute time period determine blood glucose lactate . Thus , total amount whole blood collect within trial 160ml , less half typical soft drink . Blood sample process For blood sample , 1 ml whole blood collect used immediate quantification glucose lactate ( Biosen C , EKF Diagnostics , UK ) . On sample additional 11 ml blood take , remain blood transfer tube design collect blood plasma serum . Both container centrifuge 3000 x g 15 minute obtain plasma serum , store -80 C° later analysis insulin ( Invitron , UK ) , triglyceride ( Randox Labs , UK ) , Apoliopoprotein-B48 ( Oxford Biosystems , UK ) , Apolipoprotein-B-100 ( Oxford Biosystems , UK ) , non-esterified fatty acid ( Randox Labs , UK ) , TNF-α ( Sigma Aldrich ) , GLP-1 ( Oxford Biosystems , UK ) , PYY ( Sigma Aldrich , UK ) , Total Antioxidant capacity ( Eagle Biosciences , UK ) , Human Myeloperoxidase ( Eagle Biosciences , UK ) . During blood draw , participant ask complete 10 point Likert Visual Analogue Scale ( VAS ) determine subjective feeling hunger fullness . Following blood sample completion VAS 6 hour post-meal , participant discharge laboratory .</detailed_description>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin , Short-Acting</mesh_term>
	<criteria>For inclusion study , volunteer either male female age 1850 year old free diabetes complication apart background diabetic retinopathy take prescribed medication insulin treat stable insulin regimen compose combination slow/long act insulin glargine/determir fast acting insulin analogue ( lispro aspart , glulisine ) HbA1c &lt; 9.5 % ( 80 mmol/mol ) use carbohydrate counting method administer meal time rapidacting insulin .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>